Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 4:29 pm Sale | 2025-06-30 | 13G | Compass Therapeutics, Inc. CMPX | MPM BioImpact LLC | 5,622,505 4.100% | -2,945,391 (-34.38%) | Filing History |
| 2025-02-14 4:11 pm Purchase | 2024-12-31 | 13G | Compass Therapeutics, Inc. CMPX | MPM BioImpact LLC | 8,567,896 6.200% | 8,567,896 (New Position) | Filing History |
| 2025-01-08 4:07 pm Purchase | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | MPM BioImpact LLC | 14,705,882 16.400% | 14,705,882 (New Position) | Filing History |
| 2023-08-01 10:53 am Sale | 2023-08-01 | 13D | Reunion Neuroscience Inc. REUN | MPM BioImpact LLC | 0 0.000% | -5,129,673 (Position Closed) | Filing History |
| 2023-06-12 5:30 pm Purchase | 2023-05-31 | 13D | Reunion Neuroscience Inc. REUN | MPM BioImpact LLC | 5,129,673 40.000% | 5,129,673 (New Position) | Filing History |